NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P102. A total of 2 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $41,000 | -53.4% | 142,000 | 0.0% | 0.04% | -47.7% |
| Q2 2015 | $88,000 | -10.2% | 142,000 | 0.0% | 0.09% | -6.5% |
| Q1 2015 | $98,000 | +10.1% | 142,000 | 0.0% | 0.09% | +13.6% |
| Q4 2014 | $89,000 | -27.6% | 142,000 | -3.4% | 0.08% | -34.1% |
| Q3 2014 | $123,000 | +21.8% | 147,000 | +14.8% | 0.12% | +30.9% |
| Q2 2014 | $101,000 | -37.3% | 128,000 | -7.2% | 0.09% | -39.4% |
| Q1 2014 | $161,000 | -5.3% | 138,000 | 0.0% | 0.16% | -3.7% |
| Q4 2013 | $170,000 | -28.3% | 138,000 | 0.0% | 0.16% | -33.7% |
| Q3 2013 | $237,000 | +24.7% | 138,000 | 0.0% | 0.24% | +19.1% |
| Q2 2013 | $190,000 | – | 138,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|